Sponsored Content
More Exclusive Features

Rocky start for inaugural hemp auction, but more events are planned

Optimism around a three-day hemp auction in Tennessee turned to disappointment when producers found way more sellers than buyers, driving prices down and leaving some frustrated. But organizers of the inaugural International Hemp Auction and Market, modeled after tobacco auctions in the area, say the market volatility will settle down, making future auctions more valuable. The […]

Read More

Greed, backstabbing and ‘Frankenstein contracts’ in the hemp landscape: Q&A with cannabis attorney Lisa Pittman

Hemp might be legal now, but more and more hemp companies are finding themselves in court. That’s because the booming industry has attracted a mix of new entrepreneurs and get-rich-quick scam artists looking to take advantage of a new market with few established players. Making matters more complicated for hemp businesses is the fact that many […]

Read More

The story behind a hemp extract firm’s distributor deals with major grocery, pharmacy chains

When President Donald Trump signed the 2018 Farm Bill into law, it not only made hemp a legal crop on the federal level, it also made cannabis-derived products more obtainable to consumers beyond marijuana retailers.

A side effect of this development is that securing a partnership with mainstream retail companies has become the goal of every cannabis business hoping to reach more customers and potentially see a huge increase in sales.

Read More

Federal CBD delays hurting profits and shelf space for manufacturers, companies say

CBD manufacturers have seen wide adoption of their products into mainstream retail chains in recent months, so why aren’t they turning profits as rapidly as expected? The federal government is the culprit, according to some. CV Sciences and Charlotte’s Web are among the cannabis companies that pointed to delayed federal CBD regulations as they reported […]

Read More

FDA says more scientific data needed to move forward with CBD regulation

Federal health regulators say the lack of scientific data about cannabidiol explains their delay issuing new guidance on over-the-counter CBD products. The U.S. Food and Drug Administration (FDA) continues to accept comments on hemp- and cannabis-derived ingredients, months after the comment period closed, according to Sharon Lindan Mayl, senior policy adviser in the agency’s Office […]

Read More